Skip to main content

Table 5 Relation between mRECIST and vRECIST methods in assessment of the therapeutic response whether responders or non-responders.

From: Role of multislice computed tomography 3D volumetric analysis in the assessment of the therapeutic response of hepatocellular carcinoma after transarterial chemoembolization

 

Response mRECIST

Responder

Non responder

Count

Percentage

Count

Percentage

Response vRECIST

Responder

13

92.9%

25

69.4%

Nonresponder

1

7.1%

11

30.6%

Measure of agreement

Kappa

P value

.154

.140